Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer
PHASE2
The purpose of this study is to evaluate the clinical efficacy and safety o...
A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer
PHASE2
The study is being conducted to evaluate the clinical efficacy of HLX87 in ...
A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients
PHASE2
This is a Phase II Study of HLX22 in Combination with Trastuzumab Deruxteca...